Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations

Nath, 1995, Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, Med. Phys., 22, 209, 10.1118/1.597458

Interstitial Brachytherapy: Physical, Biological, and Clinical Considerations

Principles and Practice of Radiation Oncology

Meigooni, 2000, Response to ‘Comment on Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43’, Med. Phys., 27, 265, 10.1118/1.598869

Kline, 1996, Comment on ‘Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43’, Med. Phys., 23, 1579, 10.1118/1.597889

Fung, 1998, Comment on ‘Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43’, Med. Phys., 25, 2477, 10.1118/1.598439

Williamson, 2000, Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription (AAPM Report No. 69), Med. Phys., 27, 634, 10.1118/1.598923

Williamson, 1999, On the use of apparent activity (Aapp) for treatment planning of 125I and 103Pd interstitial brachytherapy sources: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Subcommittee on Low-Energy Brachytherapy Source Dosimetry, Med. Phys., 26, 2529, 10.1118/1.598789

Williamson, 1998, Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources, Med. Phys., 25, 2269, 10.1118/1.598456

http://rpc.mdanderson.org/rpc/htm/Home_htm/Low-energy.htm

Atlas of Brachytherapy

Lee, 2003, Limited resection for non-small cell lung cancer: Observed local control with implantation of I-125 brachytherapy seeds, Ann. Thorac. Surg., 75, 237, 10.1016/S0003-4975(02)04098-5

Yu, 1999, Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group Report No. 64, Med. Phys., 26, 2054, 10.1118/1.598721

Mettlin, 1998, The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S., Cancer, 83, 1679, 10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y

Ragde, 1998, Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma, Cancer, 83, 989, 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q

Whitmore, 1972, Retropubic implantation of iodine-125 in the treatment of prostatic cancer, J. Urol. (Paris), 108, 918

R. E. Peschel C. R. King K. Roberts 14

Zelefsky, 1997, Long-term results of retropubic permanent 125Iodine implantation of the prostate for clinically localized prostatic cancer, J. Urol. (Paris), 158, 23

Nath, 1998, Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants, Med. Phys., 25, 2293, 10.1118/1.598440

Stock, 1998, A dose-response study for I-125 prostate implants, Int. J. Radiat. Oncol., Biol., Phys., 41, 101, 10.1016/S0360-3016(98)00006-6

Potters, 2001, A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy, Int. J. Radiat. Oncol., Biol., Phys., 50, 605, 10.1016/S0360-3016(01)01473-0

Proceedings of 2000 World Congress on Medical Physics and Biomedical Engineering

Rivard, 1999, Refinements to the geometry factor used in the AAPM Task Group Report No. 43 necessary for brachytherapy dosimetry calculations, Med. Phys., 26, 2445, 10.1118/1.598764

Rivard, 2000, Neutron dosimetry for a general 252Cf brachytherapy source, Med. Phys., 27, 2803, 10.1118/1.1326445

Kouwenhoven, 2001, Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry, Med. Phys., 28, 1965, 10.1118/1.1398563

Meli, 2002, Let's abandon geometry factors other than that of a point source in brachytherapy dosimetry, Med. Phys., 29, 1917, 10.1118/1.1496099

Rivard, 2002, Comment on ‘Let's abandon geometry factors other than that of a point source in brachytherapy dosimetry’, Med. Phys., 29, 1919, 10.1118/1.1496100

Rivard, 1999, Comments on ‘Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43’, Med. Phys., 26, 2514, 10.1118/1.598773

Moss, 2000, Improved analytical fit to the TG-43 radial dose function, g(r),, Med. Phys., 27, 659, 10.1118/1.598926

Lindsay, 2001, The effect of seed anisotropy on brachytherapy dose distributions using 125I and 103Pd,, Med. Phys., 28, 336, 10.1118/1.1350674

Corbett, 2001, The effect of seed orientation deviations on the quality of 125I prostate implants, Phys. Med. Biol., 46, 2785, 10.1088/0031-9155/46/11/303

Nath, 2002, Status of the American Association of Physicist in Medicine Radiation Therapy Committee Subcommittee's Low-Energy Interstitial Brachytherapy Source Dosimetry: Procedure for the development of consensus single source dose distributions, Med. Phys., 29, 1349

Williamson, 1999, Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry, Med. Phys., 26, 570, 10.1118/1.598570

Williamson, 1991, Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds, Med. Phys., 18, 776, 10.1118/1.596631

Gearheart, 2000, Dosimetric characteristics of a new 125I brachytherapy source, Med. Phys., 27, 2278, 10.1118/1.1290486

Nath, 2000, Dose distribution along the transverse axis of a new 125I source for interstitial brachytherapy, Med. Phys., 27, 2536, 10.1118/1.1319520

Monroe, 2002, Monte Carlo-aided dosimetry of the Theragenics TheraSeed® Model 200 103Pd interstitial brachytherapy seed, Med. Phys., 29, 609, 10.1118/1.1460876

Hedtjarn, 2000, Monte Carlo-aided dosimetry of the Symmetra model 125.S06 125I, interstitial brachytherapy seed, Med. Phys., 27, 1076, 10.1118/1.598990

Hubbell, 1999, Review of photon interaction cross section data in the medical and biological context, Phys. Med. Biol., 44, R1, 10.1088/0031-9155/44/1/001

Williamson, 2002, Dosimetric characteristics of the DraxImage Model LS-1 I-125 interstitial brachytherapy source design: A Monte Carlo investigation, Med. Phys., 29, 509, 10.1118/1.1452733

Rivard, 2001, Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the MED3631-A/M 125I source, Med. Phys., 28, 629, 10.1118/1.1355306

Williamson, 2000, Monte Carlo modeling of the transverse-axis dose distribution of the Model 200 103Pd interstitial brachytherapy source, Med. Phys., 27, 643, 10.1118/1.598924

Levenson, 2000, An approach to combining results from multiple methods motivated by the ISO GUM, J. Res. Natl. Inst. Stand. Technol., 105, 571, 10.6028/jres.105.047

Li, 2000, Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source, Med. Phys., 27, 1275, 10.1118/1.599005

Li, 1993, Monte Carlo calculation of kerma-to-a-point in the vicinity of media interfaces, Phys. Med. Biol., 38, 1825, 10.1088/0031-9155/38/12/009

Kron, 1999, A checklist for reporting of thermoluminescence dosimetry (TLD) measurements, Phys. Med. Biol., 44, L15, 10.1088/0031-9155/44/10/406

Williamson, 1988, Monte Carlo evaluation of specific dose constants in water for 125I seeds, Med. Phys., 15, 686, 10.1118/1.596181

http://www.nndc.bnl.gov/nndc/nudat/

http://nucleardata.nuclear.lu.se/nucleardata/toi/

Seltzer, 1993, Calculation of photon mass energy-transfer and mass energy-absorption coefficients, Radiat. Res., 136, 147, 10.2307/3578607

Z = 1

Rivard, 1999, Mass attenuation coefficients of Clear-Pb® for photons from 125I,103Pd,99mTc,192Ir,137Cs, and 60Co,, Health Phys., 77, 571, 10.1097/00004032-199911000-00011

Patel, 2001, Thermoluminescent dosimetry of the Symmetra™ 125I model I25.S06 interstitial brachytherapy seed, Med. Phys., 28, 1761, 10.1118/1.1388218

103 Pd 18

Meigooni, 1995, Instrumentation and dosimeter-size artifacts in quantitative thermoluminescent dosimetry of low-dose fields, Med. Phys., 22, 555, 10.1118/1.597555

da Rosa, 1988, Thermoluminescent dosimeters for exposure assessment in gamma or x radiation fields with unknown spectral distribution, Appl. Radiat. Isot., 39, 191, 10.1016/0883-2889(88)90171-2

Das, 1996, Accuracy of Monte Carlo photon transport simulation in characterizing brachytherapy dosimeter energy response artifacts, Phys. Med. Biol., 41, 995, 10.1088/0031-9155/41/6/004

Williamson, 1999, Plastic scintillator response to low-energy photons, Phys. Med. Biol., 44, 857, 10.1088/0031-9155/44/4/004

Schell, 1987, Dose distributions of model 6702 I-125 seeds in water, Int. J. Radiat. Oncol., Biol., Phys., 13, 795, 10.1016/0360-3016(87)90302-6

Chiu-Tsao, 1990, Dose rate determination for 125I seeds, Med. Phys., 17, 815, 10.1118/1.596586

Piermattei, 1995, p -type silicon detector for brachytherapy dosimetry, Med. Phys., 22, 835, 10.1118/1.597486

Williamson, 1993, Comparison of calculated and measured heterogeneity correction factors for 125I,137Cs, and 192Ir brachytherapy sources near localized heterogeneities, Med. Phys., 20, 209, 10.1118/1.597088

Ahmad, 1992, Diode dosimetry of models 6711 and 6712 125I seeds in a water phantom, Med. Phys., 19, 391, 10.1118/1.596872

Ling, 1985, Two-dimensional dose distribution of 125I seeds, Med. Phys., 12, 652, 10.1118/1.595689

Bohm, 2001, Measurements and Monte Carlo calculations to determine the absolute detector response of radiochromic film for brachytherapy dosimetry, Med. Phys., 28, 142, 10.1118/1.1333412

Niroomand-Rad, 1998, Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy Committee Task Group 55, Med. Phys., 25, 2093, 10.1118/1.598407

Flühs, 1996, Direct reading measurement of absorbed dose with plastic scintillators-The general concept and applications to ophthalmic plaque dosimetry, Med. Phys., 23, 427, 10.1118/1.597736

Kirov, 1999, Towards two-dimensional brachytherapy dosimetry using plastic scintillator: New highly efficient water equivalent plastic scintillator materials, Med. Phys., 26, 1515, 10.1118/1.598647

Chiu-Tsao, 1994, High-sensitivity GafChromic film dosimetry for 125I seed, Med. Phys., 21, 651, 10.1118/1.597245

Dempsey, 1999, Quantitative optical densitometry with scanning-laser film digitizers, Med. Phys., 26, 1721, 10.1118/1.598664

Chan, 2002, Dosimetric properties of the new 125I BrachySeed™ model LS-1 source, Med. Phys., 29, 190, 10.1118/1.1445411

Maryanski, 1996, Radiation therapy dosimetry using magnetic resonance imaging of polymer gels, Med. Phys., 23, 699, 10.1118/1.597717

Chan, 2001, The measurement of three dimensional dose distribution of a ruthenium-106 ophthalmological applicator using magnetic resonance imaging of BANG polymer gels, J. Appl. Clin. Med. Phys., 2, 85

Hasson, 1998, Chemical dosimetry in the near-zone of brachytherapy sources, Med. Phys., 25, 2076, 10.1118/1.598432

Meigooni, 2001, Dosimetric characteristics of the Best® double-wall 103Pd brachytherapy source, Med. Phys., 28, 2568, 10.1118/1.1414007

Meigooni, 1994, A comparative study of dosimetric properties of Plastic Water and Solid Water in brachytherapy applications, Med. Phys., 21, 1983, 10.1118/1.597232

Brachytherapy Physics

Meigooni, 1988, A comparison of solid phantoms with water for dosimetry of 125I model 6702 brachytherapy sources, Med. Phys., 15, 695, 10.1118/1.596182

Weaver, 1984, Response of LiF powder to 125I photons, Med. Phys., 11, 850, 10.1118/1.595600

Reft, 1988, The energy response of LiF TLD-100 to low and high energy photons and to high energy electrons for varying dosimeter thickness, Phys. Med. Biol., 33, 96

Davis, 2003, The response of LiF thermoluminescent dosemeters to photon beams in the energy range from 30 kV X rays to 60Co gamma rays, Radiat. Prot. Dosim., 106, 33, 10.1093/oxfordjournals.rpd.a006332

Williamson, 1987, Monte Carlo evaluation of kerma at a point for photon transport problems, Med. Phys., 14, 567, 10.1118/1.596069

Daskalov, 2002, Multigroup discrete ordinates modeling of 125I 6702 seed dose distributions using a broad energy-group cross section representation, Med. Phys., 29, 113, 10.1118/1.1429238

Williamson, 1991, A convolution algorithm for brachytherapy dose computations in heterogeneous geometries, Med. Phys., 18, 1256, 10.1118/1.596601

Chuanyu, 2003, Integral-transport-based deterministic brachytherapy dose calculations, Phys. Med. Biol., 48, 73, 10.1088/0031-9155/48/1/306

Weaver, 1998, Anisotropy functions for 125I and 103Pd sources, Med. Phys., 25, 2271, 10.1118/1.598458

DeMarco, 2002, An analysis of MCNP cross-sections and tally methods for low-energy photon emitters, Phys. Med. Biol., 47, 1321, 10.1088/0031-9155/47/8/307

Storm, 1970, Photon cross-sections from 1 keV to 100 MeV for elements Z=1 to Z=100,, Nucl. Data, Sect. A, 7, 566

Alberti, 1993, Autoradiography for Iodine-125 seeds, Int. J. Radiat. Oncol., Biol., Phys., 25, 881, 10.1016/0360-3016(93)90319-Q

Brachytherapy Physics

Kutcher, 1994, Comprehensive QA for radiation oncology: Report of the AAPM Radiation Therapy Committee Task Group 40, Med. Phys., 21, 581, 10.1118/1.597316

Fraass, 1998, American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning, Med. Phys., 25, 1773, 10.1118/1.598373

Nath, 1997, Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56, Med. Phys., 24, 1557, 10.1118/1.597966

Nath, 1993, Anisotropy functions for Pd-103, I-125, and Ir-192 interstitial brachytherapy sources, Med. Phys., 20, 1465, 10.1118/1.597110

Sloboda, 2000, Experimental determination of the anisotropy function and anisotropy factor for model 6711 I-125 seeds, Med. Phys., 27, 1789, 10.1118/1.1287285

Furhang, 1999, Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43, Med. Phys., 26, 153, 10.1118/1.598497

Nath, 1990, Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources, Med. Phys., 17, 1032, 10.1118/1.596584

Weaver, 1989, Dose parameters of 125I and 192Ir seed sources, Med. Phys., 16, 636, 10.1118/1.596322

103 Pd 125 I Proceedings of 2000 World Congress on Medical Physics and Biomedical Engineering

Chen, 2001, Dose rate constant and energy spectrum of interstitial brachytherapy sources, Med. Phys., 28, 86, 10.1118/1.1333748

Mainegra, 2000, Radial dose functions for 103Pd,125I,169Yb, and 192Ir brachytherapy sources: an EGS4 Monte Carlo study, Phys. Med. Biol., 45, 703, 10.1088/0031-9155/45/3/309

Capote, 2001, Anisotropy functions for low energy interstitial brachytherapy sources: an EGS4 Monte Carlo study, Phys. Med. Biol., 46, 135, 10.1088/0031-9155/46/1/310

http://physics.nist.gov/photoncs

Rustgi, 1992, Photon spectral characteristics of a new double-walled iodine-125 source, Med. Phys., 19, 927, 10.1118/1.596780

Nath, 1993, Dosimetric characteristics of a double wall 125I source for interstitial brachytherapy, Med. Phys., 20, 1475, 10.1118/1.597158

Meigooni, 2000, Experimental determination of dosimetric characteristics of Best 125I brachytherapy source, Med. Phys., 27, 2168, 10.1118/1.1289256

R. Nath N. Yue 1

Sowards, 2002, Monte Carlo evaluation of the dosimetric characteristics of the Best model 2301 I-125 brachytherapy source, Appl. Radiat. Isot., 57, 327, 10.1016/S0969-8043(02)00124-0

Rivard, 2001, Comment on ‘Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source’, Med. Phys., 28, 704, 10.1118/1.1359442

Wallace, 1999, Report on the dosimetry of a new design 125Iodine brachytherapy source, Med. Phys., 26, 1925, 10.1118/1.598737

Wallace, 1998, Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism, Med. Phys., 25, 2190, 10.1118/1.598416

Wierzbicki, 1998, Calculated dosimetric parameters of the IoGold 125I source model 3631-A, Med. Phys., 25, 2197, 10.1118/1.598417

Wierzbicki, 1999, Radiographic characterization and energy spectrum of the IoGold 125I source model 3631-A/S, Med. Phys., 26, 392, 10.1118/1.598543

Rivard, 1999, Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol, Med. Phys., 26, 87, 10.1118/1.598472

Rivard, 1999, Dosimetry for 252Cf neutron emitting brachytherapy sources: Protocol, measurements, and calculations, Med. Phys., 26, 1503, 10.1118/1.598646

Rivard, 2000, Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: Applications for neutron capture therapy, Med. Phys., 27, 1761, 10.1118/1.1286723

S K , 85 std S K , 99 std

Ibbott, 2001, Dose-rate constant for Imagyn 125I brachytherapy source, Med. Phys., 28, 705, 10.1118/1.1359443

Ibbott, 2002, Monte Carlo determination of dose rate constant, Med. Phys., 29, 1637, 10.1118/1.1489046

125 I 103 Pd http://rpc.mdanderson.org/rpc/htm/Home_htm/Low-energy%20documents/ImpNotice_EndUsers_v12.pdf

Nath, 2000, Measurement of dose-rate constant for 103Pd seeds with air kerma strength calibration based upon a primary national standard, Med. Phys., 27, 655, 10.1118/1.598925

A. S. Meigooni S. Sabnis R. Nath 103 Pd 6

Yue, 2002, Experimental determination of the anisotropy function for the Model 200 103Pd “light seed” and derivation of the anisotropy constant based upon the linear quadratic model, Med. Phys., 29, 1120, 10.1118/1.1481876

Wallace, 1999, Dosimetric characterization of a new design 103palladium brachytherapy source, Med. Phys., 26, 2465, 10.1118/1.598765

Luxton, 1994, Comparison of radiation dosimetry in water and solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study, Med. Phys., 21, 631, 10.1118/1.597317

Wallace, 1998, On the conversion of dosimetric data among phantom materials for 125I and 103Pd brachytherapy sources using build-up factor methods with spectral conditions, Med. Phys., 25, A172

Li, 2000, Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source, Med. Phys., 27, 1108, 10.1118/1.598975

Rivard, 2001, A discretized approach to determining TG-43 brachytherapy dosimetry parameters: Case study using Monte Carlo calculations for the MED3633 103Pd source, Appl. Radiat. Isot., 55, 775, 10.1016/S0969-8043(01)00144-0

Luxton, 1999, Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV: EGS4 Monte Carlo calculation, Med. Phys., 26, 2531, 10.1118/1.598790

Carlsson, 2000, The collapsed cone superposition algorithm applied to scatter dose calculations in brachytherapy, Med. Phys., 27, 2320, 10.1118/1.1290485

Loftus, 1970, Standardization of cesium-137 gamma-ray sources in terms of exposure units (roentgens), J. Res. Natl. Bur. Stand., Sect. A, 74A, 1, 10.6028/jres.074A.001

Loftus, 1984, Exposure standardization of iodine-125 seeds used for brachytherapy, J. Res. Natl. Bur. Stand., 89, 295, 10.6028/jres.089.017

Ritz, 1960, Standard free-air chamber for the measurement of low energy x rays (20-100 kilovolts-constant-potential), J. Res. Natl. Bur. Stand., Sect. C, 64C, 49, 10.6028/jres.064C.007

Kubo, 1998, Report of the ad hoc committee of the AAPM Radiation Therapy Committee on 125I sealed source dosimetry, Int. J. Radiat. Oncol., Biol., Phys., 40, 697, 10.1016/S0360-3016(97)00767-0

Kubo, 1985, Exposure contribution from Ti K x rays produced in the titanium capsule of the clinical 125I seed, Med. Phys., 12, 215, 10.1118/1.595776

Loevinger, 1993, Wide-angle free-air chamber for calibration of low-energy brachytherapy sources, Med. Phys., 20, 907

Kirov, 2001, Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source, Med. Phys., 28, 764, 10.1118/1.1367280

Kirov, 2002, Med. Phys., 29, 262, 10.1118/1.1446107

Seltzer, 2003, New national air-kerma-strength standards for 125 I and 103 Pd brachytherapy seeds, J. Res. Natl. Inst. Stand. Technol., 108, 337, 10.6028/jres.108.030

DeWerd, 2004, Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: Recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine, Med. Phys., 31, 675, 10.1118/1.1645681

Williamson, 1995, Monte Carlo aided dosimetry of the microSelectron pulsed and high dose rate 192Ir sources, Med. Phys., 22, 809, 10.1118/1.597483

Rivard, 2002, Comprehensive Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the Model 3500 I-Plant 125I brachytherapy source, Appl. Radiat. Isot., 57, 381, 10.1016/S0969-8043(02)00110-0

Daskalov, 1998, Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source, Med. Phys., 25, 2200, 10.1118/1.598418

Earle, 1987, Selection of iodine 125 for the Collaborative Ocular Melanoma study, Arch. Opthalmol., 105, 763, 10.1001/archopht.1987.01060060049030

Astrahan, 1990, Optimization of 125I opthalmic plaque brachytherapy, Med. Phys., 17, 1053, 10.1118/1.596585

Nag, 2003, The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas, Int. J. Radiat. Oncol., Biol., Phys., 56, 544, 10.1016/S0360-3016(03)00006-3

Krintz, 2003, A reanalysis of the Collaborative Ocular Melanoma study medium tumor trial eye plaque dosimetry, Int. J. Radiat. Oncol., Biol., Phys., 56, 889, 10.1016/S0360-3016(03)00211-6